Oral vanadium administration to streptozotocin-diabetic rats has marked negative side-effects which are independent of the form of vanadium used

J. L. Domingo, M. Gomez, J. M. Llobet, J. Corbella, Carl L Keen

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

In the present investigation, the effects of oral administration of sodium metavanadate, sodium orthovanadate and vanadyl sulphate to alleviate some signs of diabetes in streptozotocin-treated rats have been evaluated. Streptozotocin-induced diabetic rats drank aqueous solutions (NaCl, 80mM) containing sodium metavanadate (0.15 mg/ml), sodium orthovanadate (0.23 mg/ml), or vanadyl sulphate pentahydrate (0.31 mg/ml) for 28 days. The vanadium-treated animals were compared to controls, either diabetic or nondiabetic, receiving drinking water containing NaCl (80 mM) only. Daily food and fluid intake were significantly decreased in the vanadium-treated animals relative to diabetic controls. Also, vanadium treatment reduced the level of hyperglycemia in diabetic rats, with sodium metavanadate being the most effective of the vanadium compounds tested. However, daily vanadium intake was significantly lower in the animals receiving sodium metavanadate. Signs of toxicity were observed in all vanadium-treated animals as evidenced by some deaths, decreased weight gain, and increased serum concentrations of urea and creatinine. Moreover, vanadium was detected in all tissues analyzed. Although some signs of diabetes were improved by vanadium treatment, because of the severe toxic side effects noted in all of the vanadium-treated animals, it seems evident that oral vanadium administration is not a suitable therapy of diabetes mellitus in streptozotocin-diabetic rats.

Original languageEnglish (US)
Pages (from-to)279-287
Number of pages9
JournalToxicology
Volume66
Issue number3
DOIs
StatePublished - Mar 11 1991

Fingerprint

Vanadium
Streptozocin
Oral Administration
Rats
Vanadates
Sodium
Animals
Medical problems
Vanadium Compounds
Experimental Diabetes Mellitus
Poisons
Drinking Water
Hyperglycemia
Weight Gain
Toxicity
Urea
Creatinine
Diabetes Mellitus
Therapeutics
Eating

Keywords

  • Diabetes
  • Metavanadate
  • Orthovanadate
  • Rats
  • Vanadyl

ASJC Scopus subject areas

  • Toxicology

Cite this

Oral vanadium administration to streptozotocin-diabetic rats has marked negative side-effects which are independent of the form of vanadium used. / Domingo, J. L.; Gomez, M.; Llobet, J. M.; Corbella, J.; Keen, Carl L.

In: Toxicology, Vol. 66, No. 3, 11.03.1991, p. 279-287.

Research output: Contribution to journalArticle

Domingo, J. L. ; Gomez, M. ; Llobet, J. M. ; Corbella, J. ; Keen, Carl L. / Oral vanadium administration to streptozotocin-diabetic rats has marked negative side-effects which are independent of the form of vanadium used. In: Toxicology. 1991 ; Vol. 66, No. 3. pp. 279-287.
@article{c73b02ab74e549a8abc0cd6b8842bc77,
title = "Oral vanadium administration to streptozotocin-diabetic rats has marked negative side-effects which are independent of the form of vanadium used",
abstract = "In the present investigation, the effects of oral administration of sodium metavanadate, sodium orthovanadate and vanadyl sulphate to alleviate some signs of diabetes in streptozotocin-treated rats have been evaluated. Streptozotocin-induced diabetic rats drank aqueous solutions (NaCl, 80mM) containing sodium metavanadate (0.15 mg/ml), sodium orthovanadate (0.23 mg/ml), or vanadyl sulphate pentahydrate (0.31 mg/ml) for 28 days. The vanadium-treated animals were compared to controls, either diabetic or nondiabetic, receiving drinking water containing NaCl (80 mM) only. Daily food and fluid intake were significantly decreased in the vanadium-treated animals relative to diabetic controls. Also, vanadium treatment reduced the level of hyperglycemia in diabetic rats, with sodium metavanadate being the most effective of the vanadium compounds tested. However, daily vanadium intake was significantly lower in the animals receiving sodium metavanadate. Signs of toxicity were observed in all vanadium-treated animals as evidenced by some deaths, decreased weight gain, and increased serum concentrations of urea and creatinine. Moreover, vanadium was detected in all tissues analyzed. Although some signs of diabetes were improved by vanadium treatment, because of the severe toxic side effects noted in all of the vanadium-treated animals, it seems evident that oral vanadium administration is not a suitable therapy of diabetes mellitus in streptozotocin-diabetic rats.",
keywords = "Diabetes, Metavanadate, Orthovanadate, Rats, Vanadyl",
author = "Domingo, {J. L.} and M. Gomez and Llobet, {J. M.} and J. Corbella and Keen, {Carl L}",
year = "1991",
month = "3",
day = "11",
doi = "10.1016/0300-483X(91)90199-B",
language = "English (US)",
volume = "66",
pages = "279--287",
journal = "Toxicology",
issn = "0300-483X",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Oral vanadium administration to streptozotocin-diabetic rats has marked negative side-effects which are independent of the form of vanadium used

AU - Domingo, J. L.

AU - Gomez, M.

AU - Llobet, J. M.

AU - Corbella, J.

AU - Keen, Carl L

PY - 1991/3/11

Y1 - 1991/3/11

N2 - In the present investigation, the effects of oral administration of sodium metavanadate, sodium orthovanadate and vanadyl sulphate to alleviate some signs of diabetes in streptozotocin-treated rats have been evaluated. Streptozotocin-induced diabetic rats drank aqueous solutions (NaCl, 80mM) containing sodium metavanadate (0.15 mg/ml), sodium orthovanadate (0.23 mg/ml), or vanadyl sulphate pentahydrate (0.31 mg/ml) for 28 days. The vanadium-treated animals were compared to controls, either diabetic or nondiabetic, receiving drinking water containing NaCl (80 mM) only. Daily food and fluid intake were significantly decreased in the vanadium-treated animals relative to diabetic controls. Also, vanadium treatment reduced the level of hyperglycemia in diabetic rats, with sodium metavanadate being the most effective of the vanadium compounds tested. However, daily vanadium intake was significantly lower in the animals receiving sodium metavanadate. Signs of toxicity were observed in all vanadium-treated animals as evidenced by some deaths, decreased weight gain, and increased serum concentrations of urea and creatinine. Moreover, vanadium was detected in all tissues analyzed. Although some signs of diabetes were improved by vanadium treatment, because of the severe toxic side effects noted in all of the vanadium-treated animals, it seems evident that oral vanadium administration is not a suitable therapy of diabetes mellitus in streptozotocin-diabetic rats.

AB - In the present investigation, the effects of oral administration of sodium metavanadate, sodium orthovanadate and vanadyl sulphate to alleviate some signs of diabetes in streptozotocin-treated rats have been evaluated. Streptozotocin-induced diabetic rats drank aqueous solutions (NaCl, 80mM) containing sodium metavanadate (0.15 mg/ml), sodium orthovanadate (0.23 mg/ml), or vanadyl sulphate pentahydrate (0.31 mg/ml) for 28 days. The vanadium-treated animals were compared to controls, either diabetic or nondiabetic, receiving drinking water containing NaCl (80 mM) only. Daily food and fluid intake were significantly decreased in the vanadium-treated animals relative to diabetic controls. Also, vanadium treatment reduced the level of hyperglycemia in diabetic rats, with sodium metavanadate being the most effective of the vanadium compounds tested. However, daily vanadium intake was significantly lower in the animals receiving sodium metavanadate. Signs of toxicity were observed in all vanadium-treated animals as evidenced by some deaths, decreased weight gain, and increased serum concentrations of urea and creatinine. Moreover, vanadium was detected in all tissues analyzed. Although some signs of diabetes were improved by vanadium treatment, because of the severe toxic side effects noted in all of the vanadium-treated animals, it seems evident that oral vanadium administration is not a suitable therapy of diabetes mellitus in streptozotocin-diabetic rats.

KW - Diabetes

KW - Metavanadate

KW - Orthovanadate

KW - Rats

KW - Vanadyl

UR - http://www.scopus.com/inward/record.url?scp=0026089648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026089648&partnerID=8YFLogxK

U2 - 10.1016/0300-483X(91)90199-B

DO - 10.1016/0300-483X(91)90199-B

M3 - Article

C2 - 1826377

AN - SCOPUS:0026089648

VL - 66

SP - 279

EP - 287

JO - Toxicology

JF - Toxicology

SN - 0300-483X

IS - 3

ER -